ESC 365 - microRNA-17-5p and microRNA-20a-5p downregulation by atorvastatin in Hepg2 cells: a new mechanism involved in the lipid-lowering therapy

ESC Premium Access

microRNA-17-5p and microRNA-20a-5p downregulation by atorvastatin in Hepg2 cells: a new mechanism involved in the lipid-lowering therapy

Session: Poster Session 5 - Mechanisms underlying pharmacotherapy

Topic: Lipid-Lowering Agents

Speaker: Assistant Professor K. Saavedra (Temuco, CL)

Event: ESC Congress 2019

Congress Presentation

Add to my library

About the speaker

Assistant Professor Kathleen Saavedra

University of La Frontera, Temuco (Chile)

0 follower

6 more presentations in this session

Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus

Speaker: Doctor P. Nikolaou (Athens, GR)

Atorvastatin and fenofibrate exert opposite effects on the vascularization and characteristics of visceral adipose tissue

Speaker: Doctor O. Perez-Mendez (Mexico City, MX)

The pineal hormone melatonin inhibits doxorubicin-induced mitochondrial dysfunction and apoptosis in cardiomyocytes

Speaker: Miss T. Kasi Ganeshan (London, GB)

Significative role of edoxaban on endotelial cell functions

Speaker: Miss C. Almenglo (Santiago de Compostela, ES)

Acute Cardio-Selective Functional Modulation via a Small-Molecule Direct Myosin-Attenuator (MYK-581) Preserves Diaphragmatic Function in vivo: Comparison versus Disopyramide

Speaker: Doctor C. del Rio (Brisbane, US)

Access the full session

Poster Session 5 - Mechanisms underlying pharmacotherapy

Speakers: Assistant Professor K. Saavedra, Doctor P. Nikolaou, Doctor O. Perez-Mendez, Miss T. Kasi Ganeshan, Miss C. Almenglo...

About the event

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources